The 14th International Symposium on Minimal Residual Cancer is a 3-day international symposium that covers updated aspects concerning the use of liquid biopsies in cancer patients and new developments of liquid biopsy for clinical implementation, with some specific focuses on the role of liquid biopsy in treatment decision making both for immuno-oncology and targeted therapies. Special sessions are dedicated to the new aspects of minimal residual disease detection, early detection and screening cancers, and monitoring disease by blood sampling for tracking resistance mechanisms to different therapeutic.
The symposium will include also more fundamental and translational presentations on different liquid biopsy components (Circulating Tumor Cells, exosomes, miRNA and circulating free DNA). Additionnally the perspective of liquid biopsy for the next few years will be presented.
The ISMRC 2025 is organised by the Institut RespirERA created in Nice (IHU RespirERA) and co-hosted by the European Liquid Biopsy Society (ELBS).
Plenary presentations will be given by leading international experts in different fields of liquid biopsy, as well as in cancer biology. Moreover, the ISMRC strongly supports young investigators through selected oral communications as part of plenary sessions but also poster presentations.